Synthetic fragment of Thymosin Beta-4 that promotes cell migration, angiogenesis, and systemic tissue repair through actin polymerization.
TB-500 is a synthetic version of the naturally occurring 43-amino-acid peptide Thymosin Beta-4 (Tβ4), one of the most abundant intracellular proteins in the human body. Its primary biological function is the regulation of actin — a structural protein essential for cell movement, division, and signaling. By sequestering G-actin monomers and promoting their polymerization into F-actin filaments, TB-500 enables cells to migrate to sites of injury more efficiently, making it a powerful systemic repair agent.
Unlike BPC-157, which tends to concentrate its effects locally (especially in the GI tract and at the injection site), TB-500 exerts systemic effects throughout the body due to its unique molecular structure. The peptide's active region — the central actin-binding domain — has a low molecular weight that allows it to travel through tissues with high mobility, reaching sites of injury regardless of where it is administered. This makes TB-500 particularly valuable for treating widespread or hard-to-reach tissue damage.
TB-500 also promotes angiogenesis, reduces pro-inflammatory cytokines, and has demonstrated cardioprotective properties in preclinical models, including support for cardiac tissue regeneration following ischemic events. Its anti-fibrotic effects help prevent excessive scar-tissue formation, promoting more functional healing outcomes.
Travels systemically to reach damaged tissues throughout the body, promoting cell migration and accelerating repair in muscles, tendons, ligaments, and organs.
Demonstrates cardioprotective properties including support for cardiac tissue repair, reduced fibrosis, and promotion of new blood vessel formation in the heart.
Downregulates pro-inflammatory cytokines and modulates the inflammatory cascade, reducing chronic inflammation while supporting the healing process.
Promotes satellite cell activation and differentiation, accelerating muscle fiber repair and reducing recovery time from strains and micro-tears.
Living with persistent musculoskeletal injuries that haven't responded fully to conventional treatments, seeking systemic repair support.
Recovering from surgical procedures and looking to reduce scar tissue formation, accelerate wound healing, and support systemic recovery.
Interested in supporting cardiovascular health through peptide therapy that promotes angiogenesis and reduces fibrotic tissue formation.
TB-500 is included in several physician-designed protocol stacks:
Thymosin Beta-4, the parent molecule of TB-500, has been studied extensively since its discovery in the 1960s. Research has demonstrated its role in wound healing, cardiac repair, and anti-inflammatory processes across numerous preclinical models. The synthetic fragment TB-500 preserves the active actin-binding domain of the full-length protein. Ongoing research continues to explore its applications in cardiology, orthopedics, and sports medicine, with early-phase human studies supporting its favorable safety profile.
TB-500 is a synthetic peptide fragment that contains the active actin-binding region of Thymosin Beta-4. It replicates the key healing properties of the full-length protein in a more targeted form.
While both promote tissue healing, TB-500 works systemically through actin regulation and cell migration, while BPC-157 focuses on localized angiogenesis and GI repair. They are often prescribed together for synergistic effects.
TB-500 is typically administered via subcutaneous injection. Dosing protocols are determined by your prescribing physician based on the specific condition and treatment goals.
Yes. TB-500's systemic mechanism allows it to reach and support healing in chronic, longstanding injuries. Many patients use TB-500 specifically for injuries that have plateaued with conventional treatment.
TB-500 is not currently FDA-approved as a standalone drug. It is prescribed off-label by licensed physicians and compounded at 503a/503b pharmacies under applicable regulations.
Individual results may vary. This information is for educational purposes only. All peptide therapies require a physician evaluation and prescription.
A physician will evaluate whether TB-500 is right for your recovery goals.
Check Your Eligibility →